The NKG2D receptor and its ligands-recognition beyond the "missing self"?

Microbes and Infection

Volumn 5, Issue 1, 2003, Pages 31-37

  Watzl, Carsten ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Co stimulation; Lymphocyte activation; NK cells; Signal transduction; T lymphocyte; Tumor immunity

Indexed keywords

CD8 ANTIGEN; CELL SURFACE RECEPTOR; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR NKG2D; PROTEIN DERIVATIVE; PROTEIN H60; PROTEIN MICA; PROTEIN MICB; PROTEIN RAE 1ALPHA; PROTEIN RAE 1BETA; PROTEIN RAE 1DELTA; PROTEIN RAE 1EPSILON; PROTEIN RAE 1GAMMA; PROTEIN ULBP1; PROTEIN ULBP2; PROTEIN ULBP3; UNCLASSIFIED DRUG;

BINDING AFFINITY; CELL ACTIVITY; CELL FUNCTION; CYTOMEGALOVIRUS INFECTION; ENTEROBACTER INFECTION; ESCHERICHIA COLI; HUMAN; HUMAN CYTOMEGALOVIRUS; LIGAND BINDING; MOLECULAR RECOGNITION; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STRESS; T LYMPHOCYTE; TARGET CELL; TUMOR CELL;

ANIMALS; BINDING SITES; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; KILLER CELLS, NATURAL; LIGANDS; MICE; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION;

EID: 0037278734     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(02)00057-6     Document Type: Review

References (52)

1. Karre K., Ljunggren H.G., Piontek G., Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature. 319:1986;675-678.
2. Long E.O., Barber D.F., Burshtyn D.N., Faure M., Peterson M., Rajagopalan S., Renard V., Sandusky M., Stebbins C.C., Wagtmann N., Watzl C. Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158). Immunol. Rev. 181:2001;223-233.
3. Anderson S.K., Ortaldo J.R., McVicar D.W. The ever-expanding Ly49 gene family: repertoire and signaling. Immunol. Rev. 181:2001;79-89.
4. O'Callaghan C.A. Natural killer cell surveillance of intracellular antigen processing pathways mediated by recognition of HLA-E and Qa-1b by CD94/NKG2 receptors. Microbes Infect. 2:2000;371-380.
5. McVicar D.W., Burshtyn D.N. Intracellular signaling by the killer immunoglobulin-like receptors and Ly49. Sci. STKE. 2001:2001;RE1.
6. Biassoni R., Cantoni C., Pende D., Sivori S., Parolini S., Vitale M., Bottino C., Moretta A. Human natural killer cell receptors and co-receptors. Immunol. Rev. 181:2001;203-214.
7. Houchins J.P., Yabe T., McSherry C., Bach F.H. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J. Exp. M. 173:1991;1017-1020.
8. Ho E.L., Heusel J.W., Brown M.G., Matsumoto K., Scalzo A.A., Yokoyama W.M. Murine Nkg2d and Cd94 are clustered within the natural killer complex and are expressed independently in natural killer cells. Proc. Natl. Acad. Sci. USA. 95:1998;6320-6325.
9. Yim D., Jie H.B., Sotiriadis J., Kim Y.S., Kim K.S., Rothschild M.F., Lanier L.L., Kim Y.B. Molecular cloning and characterization of pig immunoreceptor DAP10 and NKG2D. Immunogenetics. 53:2001;243-249.
10. Govaerts M.M., Goddeeris B.M. Homologues of natural killer cell receptors NKG2-D and NKR-P1 expressed in cattle. Vet. Immunol. Immunopathol. 80:2001;339-344.
11. Shum B.P., Flodin L.R., Muir D.G., Rajalingam R., Khakoo S.I., Cleland S., Guethlein L.A., Uhrberg M., Parham P. Conservation and variation in human and common chimpanzee CD94 and NKG2 genes. J. Immunol. 168:2002;240-252.
12. LaBonte M.L., Levy D.B., Letvin N.L. Characterization of rhesus monkey CD94/NKG2 family members and identification of novel transmembrane-deleted forms of NKG2-A, B, C, and D. Immunogenetics. 51:2000;496-499.
13. Berg S.F., Dissen E., Westgaard I.H., Fossum S. Molecular characterization of rat NKR-P2, a lectin-like receptor expressed by NK cells and resting T cells. Int. Immunol. 10:1998;379-385.
14. Diefenbach A., Jamieson A.M., Liu S.D., Shastri N., Raulet D.H. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 1:2000;119-126.
15. Sutherland C.L., Chalupny N.J., Schooley K., VandenBos T., Kubin M., Cosman D. UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells. J. Immunol. 168:2002;671-679.
16. Bauer S., Groh V., Wu J., Steinle A., Phillips J.H., Lanier L.L., Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 285:1999;727-729.
17. Roberts A.I., Lee L., Schwarz E., Groh V., Spies T., Ebert E.C., Jabri B. NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment. J. Immunol. 167:2001;5527-5530.
18. Jamieson A.M., Diefenbach A., McMahon C.W., Xiong N., Carlyle J.R., Raulet D.H. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity. 17:2002;19-29.
19. Girardi M., Oppenheim D.E., Steele C.R., Lewis J.M., Glusac E., Filler R., Hobby P., Sutton B., Tigelaar R.E., Hayday A.C. Regulation of cutaneous malignancy by gammadelta T cells. Science. 294:2001;605-609.
20. Pende D., Cantoni C., Rivera P., Vitale M., Castriconi R., Marcenaro S., Nanni M., Biassoni R., Bottino C., Moretta A., Moretta L. Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. Eur. J. Immunol. 31:2001;1076-1086.
21. Cosman D., Mullberg J., Sutherland C.L., Chin W., Armitage R., Fanslow W., Kubin M., Chalupny N.J. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity. 14:2001;123-133.
22. Cerwenka A., Bakker A.B., McClanahan T., Wagner J., Wu J., Phillips J.H., Lanier L.L. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity. 12:2000;721-727.
23. Groh V., Bahram S., Bauer S., Herman A., Beauchamp M., Spies T. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc. Natl. Acad. Sci. USA. 93:1996;12445-12450.
24. Groh V., Rhinehart R., Secrist H., Bauer S., Grabstein K.H., Spies T. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc. Natl. Acad. Sci. USA. 96:1999;6879-6884.
25. Groh V., Rhinehart R., Randolph-Habecker J., Topp M.S., Riddell S.R., Spies T. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2:2001;255-260.
26. Das H., Groh V., Kuijl C., Sugita M., Morita C.T., Spies T., Bukowski J.F. MICA engagement by human Vgamma2Vdelta2 T cells enhances their antigen-dependent effector function. Immunity. 15:2001;83-93.
27. Tieng V., Le Bouguenec C., du Merle L., Bertheau P., Desreumaux P., Janin A., Charron D., Toubert A. Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA. Proc. Natl. Acad. Sci. USA. 99:2002;2977-2982.
28. Steinle A., Li P., Morris D.L., Groh V., Lanier L.L., Strong R.K., Spies T. Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family. Immunogenetics. 53:2001;279-287.
29. Zou Z., Nomura M., Takihara Y., Yasunaga T., Shimada K. Isolation and characterization of retinoic acid-inducible cDNA clones in F9 cells: a novel cDNA family encodes cell surface proteins sharing partial homology with MHC class I molecules. J. Biochem. (Tokyo). 119:1996;319-328.
30. Carayannopoulos L.N., Naidenko O.V., Kinder J., Ho E.L., Fremont D.H., Yokoyama W.M. Ligands for murine NKG2D display heterogeneous binding behavior. Eur. J. Immunol. 32:2002;597-605.
31. Malarkannan S., Shih P.P., Eden P.A., Horng T., Zuberi A.R., Christianson G., Roopenian D., Shastri N. The molecular and functional characterization of a dominant minor H antigen, H60. J. Immunol. 161:1998;3501-3509.
32. Wolan D.W., Teyton L., Rudolph M.G., Villmow B., Bauer S., Busch D.H., Wilson I.A. Crystal structure of the murine NK cell-activating receptor NKG2D at 1.95 A. Nat. Immunol. 2:2001;248-254.
33. Li P., Morris D.L., Willcox B.E., Steinle A., Spies T., Strong R.K. Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA. Nat. Immunol. 2:2001;443-451.
34. Radaev S., Rostro B., Brooks A.G., Colonna M., Sun P.D. Conformational plasticity revealed by the cocrystal structure of NKG2D and its class I MHC-like ligand ULBP3. Immunity. 15:2001;1039-1049.
35. Li P., McDermott G., Strong R.K. Crystal structures of RAE-1beta and its complex with the activating immunoreceptor NKG2D. Immunity. 16:2002;77-86.
36. O'Callaghan C.A., Cerwenka A., Willcox B.E., Lanier L.L., Bjorkman P.J. Molecular competition for NKG2D: H60 and RAE1 compete unequally for NKG2D with dominance of H60. Immunity. 15:2001;201-211.
37. Kubin M., Cassiano L., Chalupny J., Chin W., Cosman D., Fanslow W., Mullberg J., Rousseau A.M., Ulrich D., Armitage R. ULBP1, 2, 3: novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells. Eur. J. Immunol. 31:2001;1428-1437.
38. Yokoyama S., Staunton D., Fisher R., Amiot M., Fortin J.J., Thorley-Lawson D.A. Expression of the Blast-1 activation/adhesion molecule and its identification as CD48. J. Immunol. 146:1991;2192-2200.
39. Pende D., Parolini S., Pessino A., Sivori S., Augugliaro R., Morelli L., Marcenaro E., Accame L., Malaspina A., Biassoni R., Bottino C., Moretta L., Moretta A. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J. Exp. M. 190:1999;1505-1516.
40. Diefenbach A., Raulet D.H. Strategies for target cell recognition by natural killer cells. Immunol. Rev. 181:2001;170-184.
41. Matzinger P. The danger model: a renewed sense of self. Science. 296:2002;301-305.
42. Cerwenka A., Baron J.L., Lanier L.L. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc. Natl. Acad. Sci. USA. 98:2001;11521-11526.
43. Diefenbach A., Jensen E.R., Jamieson A.M., Raulet D.H. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature. 413:2001;165-171.
44. Wu J., Song Y., Bakker A.B., Bauer S., Spies T., Lanier L.L., Phillips J.H. An activating immunoreceptor complex formed by NKG2D and DAP10. Science. 285:1999;730-732.
45. Wu J., Cherwinski H., Spies T., Phillips J.H., Lanier L.L. DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells. J. Exp. M. 192:2000;1059-1068.
46. Chang C., Dietrich J., Harpur A.G., Lindquist J.A., Haude A., Loke Y.W., King A., Colonna M., Trowsdale J., Wilson M.J. Cutting edge: KAP10, a novel transmembrane adapter protein genetically linked to DAP12 but with unique signaling properties. J. Immunol. 163:1999;4651-4654.
47. Cerwenka A., Lanier L.L. Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 1:2001;41-49.
48. Wilson M.J., Lindquist J.A., Trowsdale J. DAP12 and KAP10 (DAP10)-novel transmembrane adapter proteins of the CD3zeta family. Immunol. Res. 22:2000;21-42.
49. Alegre M.L., Frauwirth K.A., Thompson C.B. T-cell regulation by CD28 and CTLA-4. Nat. Rev. Immunol. 1:2001;220-228.
50. Jiang K., Zhong B., Gilvary D.L., Corliss B.C., Hong-Geller E., Wei S., Djeu J.Y. Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells. Nat. Immunol. 1:2000;419-425.
51. Colucci F., Schweighoffer E., Tomasello E., Turner M., Ortaldo J.R., Vivier E., Tybulewicz V.L., Di Santo J.P. Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases. Nat. Immunol. 3:2002;288-294.
52. Krmpotic A., Busch D.H., Bubic I., Gebhardt F., Hengel H., Hasan M., Scalzo A.A., Koszinowski U.H., Jonjic S. MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo. Nat. Immunol. 3:2002;529-535.